MedPath
NMPA Approval

Prucalopride Succinate Tablets

国药准字H20213914

November 30, 2021

Drug Information

琥珀酸普芦卡必利片

片剂

1mg(按C18H26ClN3O3计)

化学药品

November 30, 2021

Company Information

Applicant Company

成都高新区(西区)迪康大道一号

Manufacturing Company

成都高新区(西区)迪康大道一号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

琥珀酸普芦卡必利片 - NMPA 批准文号 | MedPath